ephb receptor activity suppresses colorectal cancer progression 
sporadic colorectal cancers initiated activating wnt pathway mutations1 characterized stabilization beta-catenin constitutive transcription beta-catenin/t cell factor- tcf- complex23 ephb guidance receptors tcf4 target genes control intestinal epithelial architecture repulsive interactions ephrin-b ligands45 show although wnt signalling remains constitutively active human colorectal cancers lose expression ephb adenoma-carcinoma transition loss ephb expression strongly correlates degree malignancy furthermore reduction ephb activity accelerates tumorigenesis colon rectum apcmin/+ mice results formation aggressive adenocarcinomas data demonstrate loss ephb expression represents critical step colorectal cancer progression 
